NL300020I2 - Produktie van virus-antigenen. - Google Patents
Produktie van virus-antigenen.Info
- Publication number
- NL300020I2 NL300020I2 NL300020C NL300020C NL300020I2 NL 300020 I2 NL300020 I2 NL 300020I2 NL 300020 C NL300020 C NL 300020C NL 300020 C NL300020 C NL 300020C NL 300020 I2 NL300020 I2 NL 300020I2
- Authority
- NL
- Netherlands
- Prior art keywords
- cells
- respiratory syncytial
- syncytial virus
- produced
- antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 8
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 4
- 230000003612 virological effect Effects 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
- C12N2760/18564—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8021434 | 1980-07-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL300020I1 NL300020I1 (nl) | 2000-12-01 |
| NL300020I2 true NL300020I2 (nl) | 2001-08-01 |
Family
ID=10514423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300020C NL300020I2 (nl) | 1980-07-01 | 2000-10-04 | Produktie van virus-antigenen. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US4517304A (nl) |
| EP (1) | EP0043272B1 (nl) |
| JP (2) | JPS5740412A (nl) |
| AT (1) | ATE7855T1 (nl) |
| AU (2) | AU554080B2 (nl) |
| CA (1) | CA1188985A (nl) |
| DE (1) | DE3164143D1 (nl) |
| GB (1) | GB2079786B (nl) |
| NL (1) | NL300020I2 (nl) |
| NZ (1) | NZ197553A (nl) |
| ZA (1) | ZA814386B (nl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1267087A (en) * | 1985-02-14 | 1990-03-27 | Nicolaas Visser | Synthetic immunogen |
| CA1279818C (en) * | 1985-03-29 | 1991-02-05 | Cenfold Holdings S.A. | Diagnostic testing for micro-organisms |
| US5149650A (en) * | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
| US6291228B1 (en) | 1988-08-03 | 2001-09-18 | Vericore Limited | Vaccine |
| US5824307A (en) | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| DE4207317C3 (de) * | 1992-03-06 | 2000-03-16 | Heraeus Electro Nite Int | Vorrichtung zur Messung der Temperatur von Metallschmelzen |
| CA2162557C (en) | 1993-05-12 | 2004-09-28 | Amy J. Weiner | Conserved motif of hepatitis c virus e2/ns1 region |
| ATE196737T1 (de) † | 1993-05-25 | 2000-10-15 | American Cyanamid Co | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus |
| ATE164313T1 (de) * | 1993-08-06 | 1998-04-15 | Connaught Lab | Inaktivierte respiratorische synzytial-virus- impfstoffe |
| US7223410B1 (en) | 1994-08-05 | 2007-05-29 | Sanofi Pasteur Limited | Inactivated respiratory syncytial viral vaccines |
| US5811524A (en) * | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| GB9924990D0 (en) * | 1999-10-21 | 1999-12-22 | Glaxo Group Ltd | Medicaments |
| JP2003513935A (ja) * | 1999-11-08 | 2003-04-15 | バイオミューン | マイコプラズマ・ボビスに対するワクチンおよび使用方法 |
| DK1265928T3 (da) * | 2000-01-27 | 2010-11-15 | Medimmune Llc | RSV-neutraliserende antistoffer med ultra høj affinitet |
| AU2001240020B9 (en) * | 2000-03-01 | 2008-12-04 | Medimmune, Llc | High potency recombinant antibodies and method for producing them |
| US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
| US20060115485A1 (en) * | 2004-10-29 | 2006-06-01 | Medimmune, Inc. | Methods of preventing and treating RSV infections and related conditions |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226743A (nl) * | 1967-04-19 | 1971-03-31 | ||
| US3919044A (en) * | 1973-03-28 | 1975-11-11 | Armour Pharma | Processes for concentrating and purifying viruses and viral antigens |
| FR2227861B1 (nl) * | 1973-05-04 | 1976-07-02 | Anvar | |
| US4112068A (en) * | 1976-08-11 | 1978-09-05 | Cutter Laboratories, Inc. | Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom |
| NL7801060A (nl) * | 1977-02-09 | 1978-08-11 | Merck & Co Inc | Werkwijze voor het bereiden van een afgezwakt syncytiaal ademhalingsvirus, alsmede prepara- ten en vaccins die dit virus bevatten. |
| US4122167A (en) * | 1977-02-09 | 1978-10-24 | Merck & Co., Inc. | Respiratory synctial vaccine |
| LU79503A1 (fr) * | 1977-08-17 | 1978-11-28 | Merck & Co Inc | Procede de preparation d'un vaccin syncytial du virus respiratoire |
-
1981
- 1981-06-29 EP EP81302947A patent/EP0043272B1/en not_active Expired
- 1981-06-29 US US06/278,052 patent/US4517304A/en not_active Expired - Lifetime
- 1981-06-29 DE DE8181302947T patent/DE3164143D1/de not_active Expired
- 1981-06-29 GB GB8119979A patent/GB2079786B/en not_active Expired
- 1981-06-29 AT AT81302947T patent/ATE7855T1/de not_active IP Right Cessation
- 1981-06-29 ZA ZA814386A patent/ZA814386B/xx unknown
- 1981-06-29 CA CA000380803A patent/CA1188985A/en not_active Expired
- 1981-06-29 NZ NZ197553A patent/NZ197553A/en unknown
- 1981-06-30 AU AU72415/81A patent/AU554080B2/en not_active Expired
- 1981-06-30 JP JP56100747A patent/JPS5740412A/ja active Granted
-
1986
- 1986-06-05 AU AU58412/86A patent/AU588885B2/en not_active Expired
-
1989
- 1989-01-27 US US07/318,502 patent/US5071758A/en not_active Expired - Fee Related
-
1990
- 1990-05-01 JP JP2115712A patent/JPH02291262A/ja active Granted
-
2000
- 2000-10-04 NL NL300020C patent/NL300020I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU588885B2 (en) | 1989-09-28 |
| GB2079786A (en) | 1982-01-27 |
| NL300020I1 (nl) | 2000-12-01 |
| CA1188985A (en) | 1985-06-18 |
| JPH0380474B2 (nl) | 1991-12-25 |
| US4517304A (en) | 1985-05-14 |
| JPH0553474B2 (nl) | 1993-08-10 |
| AU554080B2 (en) | 1986-08-07 |
| EP0043272B1 (en) | 1984-06-13 |
| NZ197553A (en) | 1985-03-20 |
| ZA814386B (en) | 1982-07-28 |
| AU5841286A (en) | 1986-11-20 |
| EP0043272A1 (en) | 1982-01-06 |
| DE3164143D1 (en) | 1984-07-19 |
| JPH02291262A (ja) | 1990-12-03 |
| AU7241581A (en) | 1982-01-07 |
| GB2079786B (en) | 1984-11-14 |
| US5071758A (en) | 1991-12-10 |
| JPS5740412A (en) | 1982-03-06 |
| ATE7855T1 (de) | 1984-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300020I2 (nl) | Produktie van virus-antigenen. | |
| FI860015A (fi) | Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan | |
| NZ224581A (en) | Hiv-2 peptide, aids vaccine | |
| AU2684792A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
| ES465059A1 (es) | Un procedimiento de produccion de gamma-globulinas y acidos inmunociclicos. | |
| DE69327623D1 (de) | Herstellungsmethode um multiple-sklerose-virus-assoziierte infizierte zellen zu erhalten | |
| AU5329279A (en) | Feline infectious peritonitis vaccine | |
| DE3585578D1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| IE860315L (en) | Detecting htlv-iii neutralising antibodies | |
| DE3889581D1 (de) | Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung. | |
| FI98377B (fi) | Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi | |
| ES8200398A1 (es) | Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b. | |
| Clements | Progress in Medical Virology, Volume 37: Editor JL Melnick, Karger, SFr 227, Dm 227,£ 98.70, US $168.25, ISBN 3-8055-5077-4 | |
| TH13250EX (th) | เชื้อไวรัสที่เกี่ยวกับโรคซึ่งเกิดกับหมูโดยไม่ทราบสาเหตุ | |
| GB1279859A (en) | Process for the production of enhanced levels of viral yield | |
| ES390873A1 (es) | Un procedimiento de cultivo de virus. | |
| UA8704A1 (uk) | Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу | |
| TH32687B (th) | เชื้อไวรัสที่เกี่ยวกับโรคซึ่งเกิดกับหมูโดยไม่ทราบสาเหตุ |